Journal
HUMAN VACCINES
Volume 7, Issue 6, Pages 685-693Publisher
LANDES BIOSCIENCE
DOI: 10.4161/hv.7.6.15197
Keywords
hantavirus; vaccines; protective immunity; immunopathogenesis
Categories
Funding
- Deutsche Forschungsgemeinschaft [KR1293/9-1]
- European Commission [228292]
- Slovak Scientific Grant Agency VEGA [2/0189/09]
Ask authors/readers for more resources
Hantaviruses are emerging viruses which are hosted by small mammals. When transmitted to humans, they can cause two clinical syndromes, hemorrhagic fever with renal syndrome or hantavirus cardiopulmonary syndrome. The review compiles the current list of hantaviruses which are thought to be pathogenic in humans on the basis of molecular or at least serological evidence. Whereas induction of a neutralizing humoral immune response is considered to be protective against infection, the dual role of cellular immunity (protection versus immunopathogenicity) is discussed. For active immunisation, inactivated virus vaccines are licensed in certain Asian countries. Moreover, several classical and molecular vaccine approaches are in pre-clinical stages of development. The development of hantavirus vaccines is hampered by the lack of adequate animal models of hantavirus-associated disease. In addition to active immunization strategies, the review summarizes other ways of infection prevention, as passive immunization, chemoprophylaxis, and exposition prophylaxis.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available